These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 37514008)

  • 1. Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy.
    Hu T; Huang Y; Liu J; Shen C; Wu F; He Z
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell membrane coated-nanoparticles for cancer immunotherapy.
    Zeng Y; Li S; Zhang S; Wang L; Yuan H; Hu F
    Acta Pharm Sin B; 2022 Aug; 12(8):3233-3254. PubMed ID: 35967284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic nanoparticles for tumor immunotherapy.
    Yu H; Wu M; Chen S; Song M; Yue Y
    Front Bioeng Biotechnol; 2022; 10():989881. PubMed ID: 36440446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy.
    Wang H; Wu C; Tong X; Chen S
    J Control Release; 2023 Jan; 353():727-737. PubMed ID: 36473607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy.
    Zeng YY; Gu Q; Li D; Li AX; Liu RM; Liang JY; Liu JY
    Acta Pharmacol Sin; 2024 Jul; ():. PubMed ID: 39085407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic cell-derived nanocarriers for modulating immune responses.
    Qin M; Du G; Sun X
    Biomater Sci; 2020 Jan; 8(2):530-543. PubMed ID: 31750453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-Coated Biomimetic Nanoparticles: A State-of-the-Art Multifunctional Weapon for Tumor Immunotherapy.
    Zhang Y; Zhang X; Li H; Liu J; Wei W; Gao J
    Membranes (Basel); 2022 Jul; 12(8):. PubMed ID: 36005653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy.
    Zhong Z; Deng W; Wu J; Shang H; Tong Y; He Y; Huang Q; Ba X; Chen Z; Tang K
    Nanoscale; 2024 May; 16(18):8708-8738. PubMed ID: 38634521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic nanotechnology for cancer immunotherapy: State of the art and future perspective.
    Sarkar Lotfabadi A; Abadi B; Rezaei N
    Int J Pharm; 2024 Apr; 654():123923. PubMed ID: 38403091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
    Huang G; Liu L; Pan H; Cai L
    Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines.
    Liu J; Liew SS; Wang J; Pu K
    Adv Mater; 2022 Jan; 34(1):e2103790. PubMed ID: 34651344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
    Hussain Z; Rahim MA; Jan N; Shah H; Rawas-Qalaji M; Khan S; Sohail M; Thu HE; Ramli NA; Sarfraz RM; Abourehab MAS
    J Control Release; 2021 Jul; 335():130-157. PubMed ID: 34015400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell membrane-wrapped nanoparticles for cancer immunotherapy: A review of current developments.
    Jiang Q; Xie M; Chen R; Yan F; Ye C; Li Q; Xu S; Wu W; Jia Y; Shen P; Ruan J
    Front Immunol; 2022; 13():973601. PubMed ID: 36105816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy.
    Meng L; Teng Z; Yang S; Wang N; Guan Y; Chen X; Liu Y
    Nanoscale; 2023 Apr; 15(14):6432-6455. PubMed ID: 36916703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy.
    Li J; Zeng H; Li L; Yang Q; He L; Dong M
    ACS Nano; 2023 Dec; 17(24):24593-24618. PubMed ID: 38055350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.